Bundy GL - Search Results

1

Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.

Bleasdale JE, Thakur NR, Gremban RS, Bundy GL, Fitzpatrick FA, Smith RJ, Bunting S. Bleasdale JE, et al. Among authors: bundy gl. J Pharmacol Exp Ther. 1990 Nov;255(2):756-68. J Pharmacol Exp Ther. 1990. PMID: 2147038

2

Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness.

Smith RJ, Sam LM, Justen JM, Bundy GL, Bala GA, Bleasdale JE. Smith RJ, et al. Among authors: bundy gl. J Pharmacol Exp Ther. 1990 May;253(2):688-97. J Pharmacol Exp Ther. 1990. PMID: 2338654

3

Inhibition of phospholipase C dependent processes by U-73, 122.

Bleasdale JE, Bundy GL, Bunting S, Fitzpatrick FA, Huff RM, Sun FF, Pike JE. Bleasdale JE, et al. Among authors: bundy gl. Adv Prostaglandin Thromboxane Leukot Res. 1989;19:590-3. Adv Prostaglandin Thromboxane Leukot Res. 1989. PMID: 2526542 No abstract available.

4

Arachidonic acid and 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid modulate human polymorphonuclear neutrophil activation by monocyte derived neutrophil activating factor.

Smith RJ, Sam LM, Justen JM, Bundy GL, Fitzpatrick FA, Wynalda MA. Smith RJ, et al. Among authors: bundy gl. Biochem Biophys Res Commun. 1987 Oct 29;148(2):636-45. doi: 10.1016/0006-291x(87)90924-7. Biochem Biophys Res Commun. 1987. PMID: 2825667

5

Inhibition of human platelet thromboxane synthetase by 9,11-azoprosta-5,13-dienoic acid.

Gorman RR, Bundy GL, Peterson DC, Sun FF, Miller OV, Fitzpatrick FA. Gorman RR, et al. Among authors: bundy gl. Proc Natl Acad Sci U S A. 1977 Sep;74(9):4007-11. doi: 10.1073/pnas.74.9.4007. Proc Natl Acad Sci U S A. 1977. PMID: 269449 Free PMC article.

6

Chemical Oxidation of 2,4-Diamino-pyrrolo[2,3-d]pyrimidines.

Bundy GL, Gremban RS, Banitt LS, Palmer JR, Mizsak SA, Han F. Bundy GL, et al. J Org Chem. 1998 Oct 16;63(21):7542-7546. doi: 10.1021/jo9810664. J Org Chem. 1998. PMID: 11672414 No abstract available.

7

9,11-epoxyiminoprosta-5,13-dienoic acid is a thromboxane A2 antagonist in human platelets.

Fitzpatrick FA, Bundy GL, Gorman RR, Honohan T. Fitzpatrick FA, et al. Among authors: bundy gl. Nature. 1978 Oct 26;275(5682):764-6. doi: 10.1038/275764a0. Nature. 1978. PMID: 703845 No abstract available.

8

9,11-Iminoepoxyprosta-5,13-dienoic acid is a selective thromboxane A2 synthetase inhibitor.

Fitzpatrick F, Gorman R, Bundy G, Honohan T, McGuire J, Sun F. Fitzpatrick F, et al. Biochim Biophys Acta. 1979 May 25;573(2):238-44. doi: 10.1016/0005-2760(79)90057-2. Biochim Biophys Acta. 1979. PMID: 375987

9

An antiserum against 9,11-azo-15-hydroxyprosta-5,13-dienoic acid recognises and binds prostaglandin endoperoxides.

Fitzpatrick FA, Gorman RR, Bundy GL. Fitzpatrick FA, et al. Among authors: bundy gl. Nature. 1978 May 25;273(5660):302-4. doi: 10.1038/273302a0. Nature. 1978. PMID: 652034 No abstract available.

10

Hapten mimic elicits antibodies recognizing prostaglandin E2.

Fitzpatrick FA, Bundy GL. Fitzpatrick FA, et al. Among authors: bundy gl. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2689-93. doi: 10.1073/pnas.75.6.2689. Proc Natl Acad Sci U S A. 1978. PMID: 275836 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page